Mark Drew

Mark Drew is an accomplished professional in drug discovery and development, currently serving as the Director of Drug Discovery & Development at the Critical Path Institute since February 2023. Previously, Mark held the position of Senior Translational Project Manager at the University of Arizona's Center for Innovation in Brain Science from September 2020 to February 2023. Mark has extensive experience as a Lead Research Investigator at Icagen and Sanofi, where responsibilities included managing discovery programs and optimizing lead compounds across multiple therapeutic areas. Mark's background also features roles as a Patent Agent and membership on the Institutional Review Board at the University of Arizona, contributing to research protocol reviews and patent evaluations. Mark holds a Ph.D. in Chemistry from The University of Manchester and an NIH Post-doctoral Research Fellowship in Organic Chemistry from Indiana University–Purdue University Indianapolis.